Andrew Doyle
Question:408. Deputy Andrew Doyle asked the Minister for Health the reason the drug Roflumilast has been removed from the drugs payment scheme; and if he will make a statement on the matter. [44158/14]
View answerTuesday, 18 November 2014
Questions (408)
Written answers
The Health Service Executive (HSE) has statutory responsibility for decisions on pricing and reimbursement of medicinal products under the community drug schemes in accordance with the provisions of the Health (Pricing and Supply of Medical Goods) Act 2013, therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.
If you have not received a reply from the HSE within 15 working days please contact my Private Office and they will follow up the matter with them.